FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2015/08/006089 [Registered on: 12/08/2015] Trial Registered Prospectively
Last Modified On: 17/10/2016
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Effect of Herbal Decoction on Obesity 
Scientific Title of Study   “A STUDY OF SANTARPANIYA ADHYAYA OF CHARAKA SAMHITA IN CONTEXT TO PRINCIPLE OF MANAGEMENT FOR SANTARPAN NIMITTAJA VYADHI”  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nitin PDobariya 
Designation  MD scholar 
Affiliation  IPGT RA Jamnagar Gujarat 
Address  OPD No 18 Department of Basic Principles IPGT and RA GAU Jammagar GUJARAT India 361008
OPD No 18 Department of Basic Principles IPGT and RA GAU Jammagar GUJARAT India 361008
Jamnagar
GUJARAT
361008
India 
Phone  9925692678  
Fax    
Email  vdnitin007@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  VdHitesh vyas 
Designation  Assistant Professor 
Affiliation  IPGT RA Jamnagar Gujarat 
Address  OPD No 18 Department of Basic Principles IPGT and RA GAU Jammagar GUJARAT India 361008
OPD No 18 Department of Basic Principles IPGT and RA GAU Jammagar GUJARAT India 361008
Jamnagar
GUJARAT
361008
India 
Phone  9426433231  
Fax    
Email  drhavyas@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Prof M K Vyas 
Designation  Professor HOD 
Affiliation  IPGT RA Jamnagar Gujarat 
Address  OPD No 18 Department of Basic Principles IPGT and RA GAU Jammagar GUJARAT India 361008
OPD No 18 Department of Basic Principles IPGT and RA GAU Jammagar GUJARAT India 361008
Jamnagar
GUJARAT
361008
India 
Phone  9426953118  
Fax    
Email  drmaheshvyas@yahoo.com  
 
Source of Monetary or Material Support  
IPGT RA GAU Jamnagar Gujarat India 
 
Primary Sponsor  
Name  IPGT RA GAU Jamnagar Gujarat India 
Address  IPGT RA GAU Jamnagar Gujarat India 361008 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Nitin P Dobariya  ipgt and ra hospital  opd no 18 ipgt and ra hospital gujarat ayurveda university
Jamnagar
GUJARAT 
9925692678

vdnitin007@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  obesity,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Musta Aaragvadhadikasaya  Matra dose 2 pala 100ml Kala Nirann pratah evum sayam Kale Anupana Sukhosna jal Luke warm water Duration 60 days  
Comparator Agent  Placebo Capsule Roasted Soji  Dose 2 Capsules of 500 mg Kala Before meals two times Anupana Sukhosna jal Luke warm water  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1 Patients between the age group of 20 years to 50 years and having classical signs and symptoms of Sthaulya ie Chala Sphik Udara Stana Angagandha Swedadhikya Kshudhadhikya Pipasadhikya Kshudra Shwasa Nidradhikya will be selected irrespective of sex religion etc from the OPD and IPD of TPGT and RA Hospital GAU Jamnagar
2 Detailed clinical history will be taken on specially prepared research proforma and filled in the record of BT and AT data for the statistical study
3 BMI 25 Kg/m2 to 35 Kg/m2
 
 
ExclusionCriteria 
Details  1 Age of patient less than 20 years and more than 50 years
2 Patients having major illness like cardiac diseases diabetes mellitus etc & also the involvement of other systemic disorders
3 Patients having Sthaulya due to genetics pregnancy drug induced cushing’s syndrome hypothyroidism other hormonal disorder and related to any disease
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
s
Improvement will be assessed on the basis of
relief found in cardinal symptoms of
disease
Progress in the signs and symptoms
based on the standard pattern will be applied
before and after treatment 
60 days 
 
Secondary Outcome  
Outcome  TimePoints 
s
Improvement will be assessed on the basis of
relief found in cardinal symptoms of
disease
Progress in the signs and symptoms
based on the standard pattern will be applied
before and after treatment 
60 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   14/09/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   Not yet published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is open label clinical study to evaluate the effect of Musta Aargavadhadi kasaya on sthaulya.
Routine blood investigation will be performed to rule out other
systematic pathology.
Special scoring scale has been prepared based on information in
Ayurvedic classical texts which will be utilized for assessment and evaluation


PLAN OF STUDY:

Materials & Methods: Clinical material would be the patients, drug and research plan. Clinical study will be started only after getting clearance from institutional ethics committee.

SELECTION OF THE PATIENTS:

Inclusion Criteria:

  1. Patients between the age group of 20 years to 50 years and having classical signs and symptoms of Sthaulya i.e. Chala Sphik Udara Stana, Angagandha, Swedadhikya, Kshudhadhikya, Pipasadhikya , Kshudra Shwasa , Nidradhikya will be selected, irrespective of sex, religion etc. from the O.P.D. and I.P.D. of I.P.G.T and R.A. Hospital, G.A.U. Jamnagar.
  2. Detailed clinical history will be taken on specially prepared research proforma and filled in the record of B.T. and A.T. data for the statistical study.
  3. B.M.I. - 25 Kg/m2  to 35 Kg/m2

 

Exclusion Criteria:

1.      Age of patient less than 20 years and more than 50 years.

2.      Patients having major illness like cardiac diseases, diabetes mellitus etc & also the involvement of other systemic disorders.

3.      Patients having Sthaulya due to genetics, pregnancy, drug induced, cushing’s syndrome, hypothyroidism, other hormonal disorder and related to any disease

 

Investigations:

Investigations will be done before treatment to rule out any other associated pathology. Only important investigations related to the study will be repeated after treatment if needed. 

  1. Blood: Complete blood count and Heamogram
  2. Biochemical examination: FBS, Sr. Cholesterol, Sr. Triglyceroides, HDL, LDL, VLDL.
  3. Thyroid function test: T3, T4, TSH- When and where required.

 

 

 

 Objective Criteria:

                                                                                                                                                                                                                 

 

It will be mainly assessed on the basis of Body weight , BMI and body fat percentage before starting the treatment and after completion of the treatment in terms of percentage relief and statistical evaluations.

For the present study the girth measurements of certain regions using measuring tape before and after the treatment will also be carried out. The girth measurement of following areas where will be taken into consideration.

1. Neck            -           At the level of Thyroid cartilage.

2. Chest           -           In normal expansion at the level of nipple.

3. Abdomen    -           At the level of umbilicus.

4. Hip              -           At the level of highest point of distention of buttock

5. Mid arm      -           Mid of the arm between shoulder joint and elbow joint.

6. Mid thigh    -          Mid of the thigh between pelvic and elbow joint.

In case of girth measurements, the mean values of both sides will be taken before and after treatment.

The effectiveness of therapy on body fat will be assessed by measuring the skin fold thickness by Vernier calipers before and after the treatment in some particular areas like,

1. Skin fold thickness of the middle portion of the Biceps muscle.

2. Skin fold thickness of the middle portion of the Triceps muscle.

3. Skin fold thickness of the inferior portion of the scapula.

4. Skin fold thickness of the abdomen.

The skin fold measurement will be carried out bilaterally after exposing the skin properly in the above mentioned region. The superficial skin along with subcutaneous fat but except muscles a clinch will be made and the proportionate, which is stretched as skin fold will be measured by placing it between two points of Vernier Calipers. For all the regions, the mean values of both sides of the body before and after the treatment will be recorded.

Grouping:

Patients will be randomly divided into below mentioned 2 groups:

 

Group A: Musta Aragvadhadi Kashaya (Ca. Su. 23/12)

 

Group B:  Placebo Capsule.

 

Patients of both the groups will be suggested similar type of Vyayama and Pathyapathya

 

Dose & Posology :Group A

Matra (dose) : 2 pala-100ml

Kala  : Nirann pratah evum sayam Kale

Anupana : Sukhosna jal (Luke warm water)

Duration:   60 days

Preparation of kwath :

            Kwath of above mentioned drugs will be prepared by classical Ayurvedic method. Mixed rough powder of Kwathdravya will be boiled with quality sufficient water up to the evaporation of ¾ parts. Remaining part (1/4 ) with filtered and  will be used as medicine.

Group B: Placebo Cap.(Rosted sauji) :

Dose –2 Capsules of 500 mg.

Kala -  Before meals two times.

Anupana- Sukhosna jal( Luke warm water )

Criteria for assessment:

1.      A special scoring pattern will be developed for assessing improvement in signs and symptoms before and after treatment.

2.      Laboratory investigations conducted before and after treatment will also be considered as assessment criteria.

3.      Assessment of BMI, body fat percentage, reduction in weight and girth measurements. 

The obtained data will be analyzed statistically and presented along with explanatory notes, discussion and conclusion.

 

 
Close